EXTHERA AB has a total of 16 patent applications. Its first patent ever was published in 2006. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, medical technology and environmental technology are TOXCURE INC, HABIB NAGY A and ALBUTEC GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Environmental technology | |
#4 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Syringes | |
#5 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Larm Olle | 12 |
#2 | Bergstroem Thomas | 7 |
#3 | Adolfsson Lars | 6 |
#4 | Olle Larm | 4 |
#5 | Westermark Anders | 4 |
#6 | Lars Adolfsson | 3 |
#7 | Ward Robert S | 2 |
#8 | Thomas Bergstroem | 2 |
#9 | Anders Westermark | 2 |
#10 | Axelsson Jonas | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015023226A1 | Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion | |
EP2440216A1 | Use of a composition for the treatment of mucositis | |
CN101784294A | Device and method for restoration of the condition of blood | |
CN103203048A | Method For Extracorporeal Removal Of A Pathogenic Microbe, An Inflammatory Cell Or An Inflammatory Protein From Blood |